08:50 Chairperson’s Welcome and Opening Address

09:00 Patent Enforcement

• Assess the beneficial and negative aspects of commencing litigation in various jurisdictions;
• Save considerable amounts of money and resource with the assessment of different forms of alternative dispute resolution; and
• Evaluate the need to pursue enforcement against the value of the technology for your organisation.

Olivier Thirard
Direction Juridique Sourcing & Intellectual Property
Orange FT Group

09:45 Responding to Patent Infringement Claims

• Contrast the approach that needs to be taken in response to the infringement claim of a competitor;
• Create a negotiation and dispute management strategy to work towards mutually beneficial solution;
• Identify and assert your intellectual property rights as part of the response to the claim.

Alexander Bjorna
Director of IP of Business Development
BioTec Pharmacon

11:00 Patent Searching and Competition Monitoring

Understanding the value of patent information for R&D (as R&D is under pressure) and how this can help R&D planning

• How patent information is critical to empower researchers and developers to drive more focused and insightful innovation?
• The advantages of a roadmap to understand opportunities of internal growth

Early IP Awareness saves money, so it is important to monitor IP all the time

• How to make strategically informed decisions through the collection & analysis of information about the capabilities, plans and weaknesses of business rivals?
• The advantages of reinforcing patent information VS traditional competitive intelligence (press releases, product datasheets, journal articles, financial reports, seminar & conference proceedings, etc…)

Haydn Evans
Vice President Intellectual Property Outsourcing
CPA Global

11:45 Patent Portfolio Optimisation

• Reduce unnecessary patent filing expenditures with effective management and review across the life cycle of individual patents;
• Prioritize spend with effective and holistic cost benefit analysis of your patent portfolio; and
• Maximise lifecycle effectiveness by communicating the strategic review of your patent portfolio into the organization.

Adrian Spillmann
Head of Intellectual Property
Intercell

13:30 Clearances in Emerging Markets

• Limit risks associated with new markets by conducting a through clearance search;
• Address validity and enforceability issues succinctly in an end to end approach to your clearance efforts; and
• Promote your companies interests through the process by assessing the merits of possible validity claims over competing patents and patents pending.

David Cottam
Head of Patents
Teva Europe

14:15 Supporting Collaboration

• Protect the value to your business in all your R&D endeavours by effectively addressing IP Issues in collaboration contracts;
• Speed up discussions when you start with the question: Where does the value lie?
• Concentrate on the business critical issues by removing legal semantics from negotiations

Anders Josefsson
Senior Advisor & IPR Manager
Acreo AB

15:30 ONE-TO-ONE MEETINGS

In this session, you will be randomly matched with another attendee, speaker or solution provider for a 15-minute face-to-face discussions. Learn about each other, exchange ideas and share your informatics challenges and e-health goals. It doesn’t get more up close and personal than this!

15:45 Industry Perspective on the Merits of Greater Harmonisation of Patent Filing and Enforcement Across the EU

• Assess the potential impact of the anticipated community patent;
• Identify and tackle the issues associated with enforcement and national sovereignty under a centralised court system; and
• Discuss the possible interim initiatives that could enable better cross border harmonisation on IP issues.

Francesco Macchetto
Director of Intellectual Property
Bracco Imaging

16:30 Discussion on the Potential Benefits and Pitfalls of IP Law across the EU

With recent indication that the European Council will not be hosting the proposed international court, the questions about European harmonisation remain. Bodies are still calling for a greater congruence across EU countries but how feasible is this in practice? Enter the debate led by:

17:00 Chairperson’s Closing Remarks and End of Conference